by Darrin Disley | Apr 13, 2026 | Uncategorized
13 April 2026 Cardiogeni PLC (“Cardiogeni”, “CGNI” or the “Company”) Update on Share Exchange Agreement with Kira Health Invest AG Cardiogeni (AQSE: CGNI), a UK clinical stage biotechnology company founded by 2007 Nobel Laureate Sir Martin...
by Darrin Disley | Apr 1, 2026 | Uncategorized
1st April 2026 Cardiogeni PLC (“Cardiogeni”, “CGNI” or the “Company”) Update on Share Exchange Agreement with Kira Health Invest AG Cardiogeni (AQSE: CGNI), a UK clinical stage biotechnology company founded by 2007 Nobel Laureate Sir Martin...
by Darrin Disley | Mar 16, 2026 | Uncategorized
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE UK VERSION OF THE MARKET ABUSE REGULATION (EU NO. 596/2014) AS IT FORMS PART OF UNITED KINGDOM DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (“UK MAR”). IN ADDITION,...